BIOLASE, Inc. (NASDAQ:BIOL) Short Interest Down 74.1% in April

BIOLASE, Inc. (NASDAQ:BIOL) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 592,700 shares, a decrease of 74.1% from the March 31st total of 2,290,000 shares. Based on an average daily trading volume, of 5,510,000 shares, the short-interest ratio is presently 0.1 days. Approximately 1.9% of the company’s shares are sold short.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of BIOLASE in a research note on Friday. They set a “sell” rating on the stock.

BIOLASE Price Performance

NASDAQ:BIOL traded up $0.00 during trading hours on Friday, reaching $0.15. 663,098 shares of the company were exchanged, compared to its average volume of 4,451,342. The company has a debt-to-equity ratio of 34.06, a quick ratio of 0.68 and a current ratio of 1.26. BIOLASE has a 52-week low of $0.13 and a 52-week high of $32.09. The stock has a 50 day simple moving average of $0.15 and a 200 day simple moving average of $0.83.

BIOLASE (NASDAQ:BIOL) last released its quarterly earnings data on Thursday, March 21st. The medical technology company reported ($1.76) earnings per share (EPS) for the quarter. BIOLASE had a negative return on equity of 555.22% and a negative net margin of 41.97%. The business had revenue of $13.49 million during the quarter.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.